Cite
Tegnebratt T, Ruge E, Bader S, et al. Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches. EJNMMI Res. 2014;4(1):34doi: 10.1186/s13550-014-0034-6.
Tegnebratt, T., Ruge, E., Bader, S., Ishii, N., Aida, S., Yoshimura, Y., Ooi, C. H., Lu, L., Mitsios, N., Meresse, V., Mulder, J., Pawlak, M., Venturi, M., Tessier, J., & Stone-Elander, S. (2014). Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches. EJNMMI research, 4(1), 34. https://doi.org/10.1186/s13550-014-0034-6
Tegnebratt, Tetyana, et al. "Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches." EJNMMI research vol. 4,1 (2014): 34. doi: https://doi.org/10.1186/s13550-014-0034-6
Tegnebratt T, Ruge E, Bader S, Ishii N, Aida S, Yoshimura Y, Ooi CH, Lu L, Mitsios N, Meresse V, Mulder J, Pawlak M, Venturi M, Tessier J, Stone-Elander S. Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches. EJNMMI Res. 2014 Dec;4(1):34. doi: 10.1186/s13550-014-0034-6. Epub 2014 Sep 09. PMID: 26116108; PMCID: PMC4452660.
Copy
Download .nbib